Cumberland Pharmaceuticals Inc. (CPIX) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Cumberland Pharmaceuticals Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-20.95
Cash-Rich Deficit
P/B Ratio
2.39
Strong
WeakModerateStrong
Earnings Yield
-4.76%
Yield Gap
Profitability Health
2025Return on Equity
-11.40%
Weak
WeakModerateStrong
Operating Margin
-6.27%
Weak
WeakModerateStrong
Net Profit Margin
-6.37%
Weak
WeakModerateStrong
Growth Indicators
2025Revenue Growth
17.57%
Strong
WeakModerateStrong
Net Income Growth
56.23%
Strong
WeakModerateStrong
EPS Growth
58.70%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
1.01
Moderate
WeakModerateStrong
Quick Ratio
0.84
Weak
WeakModerateStrong
Asset Turnover
0.58x
Moderate
WeakModerateStrong
Inventory Turnover
1.07x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
8.12%
Strong
WeakModerateStrong
EV / Free Cash Flow
12.05x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.43x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.012
Strong
WeakModerateStrong
Return on Invested Capital
-6.89%
Weak
WeakModerateStrong
Cash Conversion Cycle
-536.75 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CPIX.
View Financial Statements